Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details)

v3.22.2.2
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Segment Reporting Information [Line Items]        
NET REVENUE $ 33,723 $ 38,304 $ 106,292 $ 102,137
Direct operating costs 20,406 24,124 64,866 62,719
Selling and marketing 2,504 2,375 7,314 6,469
General and administrative 6,500 5,921 18,479 17,814
Research and development 1,168 488 3,251 4,328
Change in contingent consideration (1,660) (2,890)
Depreciation and amortization 2,810 3,547 8,686 9,505
Net loss on lease termination, impairment and unoccupied lease charges 307 424 928 1,664
Total operating expenses 32,035 36,879 100,634 102,499
OPERATING INCOME (LOSS) 1,688 1,425 5,658 (362)
Healthcare IT [Member]        
Segment Reporting Information [Line Items]        
NET REVENUE 29,964 34,678 96,146 92,797
Direct operating costs 17,582 21,324 56,878 55,473
Selling and marketing 2,496 2,368 7,293 6,446
General and administrative 3,231 3,336 10,213 10,175
Research and development 1,168 488 3,251 4,328
Change in contingent consideration (1,660)   (2,890)  
Depreciation and amortization 2,721 3,459 8,420 9,251
Net loss on lease termination, impairment and unoccupied lease charges 307 424 928 1,664
Total operating expenses 25,845 31,399 84,093 87,337
OPERATING INCOME (LOSS) 4,119 3,279 12,053 5,460
Medical Practice Management [Member]        
Segment Reporting Information [Line Items]        
NET REVENUE 3,759 3,626 10,146 9,340
Direct operating costs 2,824 2,800 7,988 7,246
Selling and marketing 8 7 21 23
General and administrative 455 471 1,312 1,487
Research and development
Change in contingent consideration    
Depreciation and amortization 89 88 266 254
Net loss on lease termination, impairment and unoccupied lease charges
Total operating expenses 3,376 3,366 9,587 9,010
OPERATING INCOME (LOSS) 383 260 559 330
Unallocated Corporate Expenses [Member]        
Segment Reporting Information [Line Items]        
NET REVENUE
Direct operating costs
Selling and marketing
General and administrative 2,814 2,114 6,954 6,152
Research and development
Change in contingent consideration    
Depreciation and amortization
Net loss on lease termination, impairment and unoccupied lease charges
Total operating expenses 2,814 2,114 6,954 6,152
OPERATING INCOME (LOSS) $ (2,814) $ (2,114) $ (6,954) $ (6,152)